Larimar Therapeutics Inc

Research Larimar Therapeutics Inc (LRMR) on Bullrun: market cap USD 332.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLRMR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 332.43M
• Financial periodFY2025
• Net income-USD 165.67M
• Free cash flow-USD 113.29M

Valuation Snapshot

latest market cap is USD 332.43M.

About Larimar Therapeutics Inc

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Frequently asked questions

What is Larimar Therapeutics Inc's market cap?

Larimar Therapeutics Inc's market capitalization is USD 332.43M.

What does Larimar Therapeutics Inc do?

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.